Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Q1 EARNINGS: Rainy days for LabCorp

This article was originally published in Clinica

Executive Summary

In its first fiscal quarter, Laboratory Corporation of America (LabCorp) saw sales dip 1% to $1.43bn, while net earnings also fell from $147.2m, or $1.56 per share, in Q1 last year, to $113.1m, or $1.31 per diluted share this year. The company blamed inclement weather, which it said reduced revenue by $42m and adjusted EPS (excluding amortization) by $0.22. However, other forces are also at work, including Medicare payment reductions: test volume grew nearly 3% in Q1, but revenue per requisition decreased 3% year-on-year. For 2014, the firm is expecting revenue growth of around 2% and adjusted earnings of $6.40-6.70 per share, up slightly from previous guidance of $6.35-6.65 per share.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts